AMED (Amedisys) ROCE % : -2.99% (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Amedisys ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Amedisys's annualized ROCE % for the quarter that ended in Dec. 2024 was -2.99%.

Amedisys ROCE % Historical Data

The historical data trend for Amedisys's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys ROCE % Chart

Amedisys Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

21.68

22.34

11.76

4.42

7.29

Amedisys Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															9.52	8.86	14.09	8.94	-2.99

Amedisys ROCE % Calculation

Amedisys's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	116.98	/	( ( (2060.17 - 473.721)	+	(2138.714 - 514.392) )	/ 2 )
	=	116.98	/	( (1586.449	+	1624.322)	/ 2 )
	=	116.98	/	1605.3855
	=	7.29 %

Amedisys's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-49	/	( ( (2139.114 - 486.021)	+	(2138.714 - 514.392) )	/ 2 )
	=	-49	/	( ( 1653.093	+	1624.322 )	/ 2 )
	=	-49	/	1638.7075
	=	-2.99 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Amedisys (NAS:AMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Amedisys ROCE % Related Terms

Thank you for viewing the detailed overview of Amedisys's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Amedisys Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (NAS:AMED) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Executives

Allyson Guidroz	officer: Chief Accounting Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard M Ashworth	director, officer: President and CEO	200 WILMOT ROAD, DEERFIELD IL 60015
Michael Paul North	officer: Chief Information Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Adam Y Holton	officer: Chief People Officer	C/O CHS INC., 5500 CENEX DRIVE, INVER GROVE HEIGHTS MN 55077
Denise M. Bohnert	officer: Chief Compliance Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Nick Muscato	officer: Chief Strategy Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard A Lechleiter	director	PO BOX 32890, LOUISVILLE KY 40232-2890
Bruce D Perkins	director	500 WEST MAIN STREET, LOUISVILLE KY 40202
Christopher Gerard	officer: Chief Operating Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Vickie L Capps	director	2985 SCOTT STREET, VISTA CA 92083
Teresa L. Kline	director	C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Jeffrey A Rideout	director	2142 DEER OAK WAY, DANVILLE CA 94506
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
Molly Joel Coye	director	AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
David L Kemmerly	officer: See Remarks	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816